PROTECT your business and your clients ... 

FIND and open new sales opportunities and channels ...

MOVE your business to the next quality level ...

INCREASE the proficiency of your staff ...

Pavel Kubu

CEO

+420 775 192 888

Martin Masilko 

Consultant

+420 602 602 900

Erik Jurado

Marketing Manager

+420 604 206 911

International Cannabis and Cannabinoids Institute. Jachymova 26/2, 11 O 00. Prague 1, Czech Republic I EU

... with us, ICCI, 
International  

Cannabis and Cannabinoids Institute

Go to article: Home | Gut InstinctGo to article: In this issueGo to article: TSS Company InsightGo to article: TSS ABGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: Scandinavian Health Ltd.Go to article: The Pharma Industry BriefingGo to article: Komtur PharmaceuticalsGo to article: Komtur Pharmaceuticals Company InsightGo to article: How will the UK’s relaxed cannabis regulations impact clinical practice?Go to article: Finnair CargoGo to article: Finnair Cargo | Company InsightGo to article: Developing a new class of cancer combo drugsGo to article: Phoenix Company InsightGo to article: PhoenixGo to article: Antidepressants in the environment: combatting pharmaceutical pollutionGo to article: AtoZ-CRO GmbHGo to article: AtoZ-CRO GmbH Company InsightGo to article: Christensella: the key to unlocking gut microbiome-based drug discovery?Go to article: CBDepotGo to article: CBDepot Company InsightGo to article: Going digital to improve clinical trial enrolmentGo to article: BEAGo to article: Incretin combination therapy: a breakthrough for type 2 diabetes?Go to article: AlpexGo to article: Ebola in the DRC: vaccinating in a conflict zoneGo to article: Hemp IndustriesGo to article: Unither PharmaceuticalsGo to article: Data overload: turning challenges into opportunities in clinical trialsGo to article: ZenatekGo to article: Solving clinical research challenges: an IT perspectiveGo to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: EventsGo to article: In the next issue